Morgan Stanley Maintains Overweight on Astera Labs, Raises Price Target to $74

Benzinga · 10/09 11:44
Morgan Stanley analyst Joseph Moore maintains Astera Labs (NASDAQ:ALAB) with a Overweight and raises the price target from $55 to $74.